METTL3/16-mediated m6A modification of ZNNT1 promotes hepatocellular carcinoma progression by activating ZNNT1/osteopontin/S100A9 positive feedback loop-mediated crosstalk between macrophages and tumour cells

Huamei Wei,Wenchuan Li,Meng Yang,Quan Fang,Jiahui Nian,Youguan Huang,Qing Wei,Zihua Huang,Guoman Liu,Zuoming Xu,Anbin Hu,Jian Pu

DOI: https://doi.org/10.1016/j.clim.2024.109924

IF: 10.19

2024-04-01

Clinical Immunology

Abstract:Macrophages are the major components of tumour microenvironment, which play critical roles in tumour development. N⁶-methyladenosine (m⁶A) also contributes to tumour progression. However, the potential roles of m⁶A in modulating macrophages in hepatocellular carcinoma (HCC) are poorly understood. Here, we identified ZNNT1 as an HCC-related m⁶A modification target, which was upregulated and associated with poor prognosis of HCC. METTL3 and METTL16-mediated m⁶A modification contributed to ZNNT1 upregulation through stabilizing ZNNT1 transcript. ZNNT1 exerted oncogenic roles in HCC. Furthermore, ZNNT1 recruited and induced M2 polarization of macrophages via up-regulating osteopontin (OPN) expression and secretion. M2 Macrophages-recruited by ZNNT1-overexpressed HCC cells secreted S100A9, which further upregulated ZNNT1 expression in HCC cells via AGER/NF-κB signaling. Thus, this study demonstrates that m⁶A modification activated the ZNNT1/OPN/S100A9 positive feedback loop, which promoted macrophages recruitment and M2 polarization, and enhanced malignant features of HCC cells. m⁶A modification-triggered ZNNT1/OPN/S100A9 feedback loop represents potential therapeutic target for HCC.

immunology